Protalix BioTherapeutics Inc
(FRA:PBDA)
€
1.32
+0.040 (+3.13%)
Market Cap: 107.56 Mil
Enterprise Value: 82.33 Mil
PE Ratio: 39.50
PB Ratio: 2.73
GF Score: 68/100 Protalix BioTherapeutics Inc (FRA:PBDA) Transcripts
- 1